Skip to content

Psychedelic-assisted therapy: all studies

Page 165 of 294: studies 1,641 to 1,650 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Evidence that 5-HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.

British Journal of Pharmacology June 22, 2025 Aurelija Ippolito, Sridhar Vasudevan, Shaun Hurley et al. 9 citations

Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5-HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5-HT2A receptor ligand bias or signalling efficacy. Here, we investigated 5-HT2A receptor signalling properties of...

DOI: 10.1111/bph.70109 (opens in new tab) Full text (opens in new tab) 5‐ht2a receptor Biased agonism Psychedelic drugs 5-ht2a receptor pharmacology +15

The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review

Preprints.org June 19, 2025 Danial Daroui, Andrea Mastrostefano, Flavio Davini et al. 1 citation preprint

Background: Alcohol Use Disorder (AUD) is a chronic pathological condition with significant burdens throughout the world. Despite the effectiveness of the current pharmacological treatments, the ongoing issues with AUD and the high relapse rates necessitate the exploration of innovative therapies, including the use of psychedelic drugs, which have shown promising initial results. The purpose of...

Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer's Disease Therapy.

Cells June 19, 2025 Júlia Jarne-Ferrer, Mercè Pallàs, Christian Griñán-Ferré et al. 2 citations

Alzheimer's disease (AD) is a chronic and complex neurodegenerative disorder characterized by progressive cognitive decline, memory loss, and irreversible impairment of brain functions. The etiology of AD is multifactorial, involving a complex interplay of genetic, environmental, and physiological factors, including the aggregation of amyloid-β (Aβ) and oxidative stress (OS). The role of OS in...

Mama Cannabis and the Embodied Feminine: an Ancient Psychedelic for Modern Times

BRILL eBooks June 16, 2025 Bonnie Glass‐coffin, Saundra Shanti

This chapter describes the traditions, training, alterations of consciousness, healing ritual, and ethnomedical ideologies of Cannabis sativa, which is the oldest, most widely used, yet least considered plant teacher of the psychedelic renaissance. After briefly summarizing the recent literature about the deeply intertwined histories of Cannabis sativa and its intimate relationship with human...

Ayahuasca Ritual and Spiritual Practices for Substance Abuse Rehabilitation: the Takiwasi Model and Experience

June 16, 2025 Jacques Mabit, Fabio Friso, Matteo Politi 1 citation

The psychoactive brew Ayahuasca has a central role in the traditional medicines of the indigenous people of the Amazon basin and in recent decades has generated significant research interest among the academic community along with the revival of psychedelic medicine. The therapeutic community Takiwasi, located in Peru, leads this movement in its dedication to treatment of substance use...

DOI: 10.1163/9789004729759_023 (opens in new tab) Ayahuasca Rehabilitation Substance abuse Psychotherapist +1

Reframing psychedelic regulation: Tools, not treatments

Drug Science, Policy and Law June 16, 2025 Max Wolff, Natalie Gukasyan, Leor Roseman et al. 5 citations

Current regulation frameworks for medicines struggle to address the combination of pharmacological and psychotherapeutic elements in psychedelic therapy. We propose a more appropriate and advantageous approach may be to regulate psychedelic drugs as therapeutic tools or adjuncts to psychotherapy, rather than as treatments for specific mental disorders. Drawing parallels with anesthetics, which...

DOI: 10.1177/20503245251348272 (opens in new tab) Cognitive reframing Psychotherapist

Treating Childhood Trauma through Psilocybin

June 16, 2025 Bénédicte Mannix, F. Leron Shults, Michael J. Winkelman

This chapter describes a psychedelic healing protocol developed by Bénédicte Mannix for treating childhood trauma, explaining its therapeutic approaches and the philosophical and psychological traditions that inform her healing practices. The motivation for the development of this protocol has been to harness the power of psilocybin to heal human minds, bodies, and souls from psychological...

Treating War Trauma with Ibogaine and 5-MEO-DMT

June 16, 2025 María José Polanco, Mark D. Black

This chapter details the therapy protocols involving ibogaine utilized at The Mission Within (https://missionwithin.org) in Baja California, Mexico, as described by its founder and research director, Dr. Martin Polanco, along with psychedelic preparation/integration counselor and therapeutic facilitator, Dr. Mia Black. The chapter describes: Their personal development as ibogaine therapists and...

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology June 15, 2025 Daniël Hoyer 9 citations

Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N , N ‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g. ibogaine, ketamine and esketamine; and other atypicals e.g. dextromorphan/bupropion, esmethadone....

Psychedelic-Assisted Groups in the U.S.: A Culturally Responsive Counseling Approach

International Journal for the Advancement of Counselling June 14, 2025 Isaac Burt

Abstract Psychedelic-assisted groups (PAGs) indicate promise with clients that do not respond to traditional talk therapy. While encouraging, in the U.S., societal perceptions of psychedelics and concern of practicing outside one’s scope may cause practitioners to hesitate. To illustrate the potential effectiveness of PAGs, this article has three parts. First is a historical overview of...